Patents by Inventor Louisa Jane Quegan

Louisa Jane Quegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
    Publication number: 20210261556
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Application
    Filed: February 18, 2021
    Publication date: August 26, 2021
    Inventors: Gary Stuart TILBROOK, Louisa Jane QUEGAN
  • Short-acting benzodiazepine salts and their polymorphic forms
    Patent number: 10961250
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: March 30, 2021
    Assignee: PAION UK LIMITED
    Inventors: Gary Stuart Tilbrook, Louisa Jane Quegan
  • SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
    Publication number: 20200039990
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Applicant: PAION UK LIMITED
    Inventors: Gary Stuart TILBROOK, Louisa Jane QUEGAN
  • Short-acting benzodiazepine salts and their polymorphic forms
    Patent number: 10472365
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: November 12, 2019
    Assignee: PAION UK LIMITED
    Inventors: Gary Stuart Tilbrook, Louisa Jane Quegan
  • SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
    Publication number: 20180186803
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Applicant: PAION UK LIMITED
    Inventors: Gary Stuart Tilbrook, Louisa Jane Quegan
  • Short-acting benzodiazepine salts and their polymorphic forms
    Patent number: 9914738
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: March 13, 2018
    Assignee: PAION UK LIMITED
    Inventors: Gary Stuart Tilbrook, Louisa Jane Quegan
  • SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
    Publication number: 20180002338
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Application
    Filed: September 13, 2017
    Publication date: January 4, 2018
    Applicant: Paion UK Limited
    Inventors: Gary Stuart TILBROOK, Louisa Jane Quegan
  • Short-acting benzodiazepine salts and their polymorphic forms
    Patent number: 9777007
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 3, 2017
    Assignee: PAION UK LIMITED
    Inventors: Gary Stuart Tilbrook, Louisa Jane Quegan
  • SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS
    Publication number: 20160176881
    Abstract: The invention relates to besylate salts of the compound of formula (I): Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.
    Type: Application
    Filed: November 23, 2015
    Publication date: June 23, 2016
    Inventors: Gary Stuart TILBROOK, Louisa Jane QUEGAN
  • Salts and crystalline forms of a factor Xa inhibitor
    Patent number: 8530501
    Abstract: The present invention provides salts and crystalline forms of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, and pharmaceutical compositions and method of use thereof.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: September 10, 2013
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Louisa Jane Quegan
  • [4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREA SALTS, FORMS AND METHODS RELATED THERETO
    Publication number: 20120129876
    Abstract: The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof.
    Type: Application
    Filed: June 22, 2011
    Publication date: May 24, 2012
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Emma Sharp, Louisa Jane Quegan, Anjali Pandey, Juan Wang, Matthew Nieder, Wolin Huang
  • SALTS AND CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR
    Publication number: 20110178135
    Abstract: The present invention provides salts and crystalline forms of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, and pharmaceutical compositions and method of use thereof.
    Type: Application
    Filed: December 16, 2010
    Publication date: July 21, 2011
    Inventors: Anjali Pandey, Louisa Jane Quegan
  • [4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREA SALTS, FORMS AND METHODS RELATED THERETO
    Publication number: 20090156620
    Abstract: The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof.
    Type: Application
    Filed: November 5, 2008
    Publication date: June 18, 2009
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Emma Sharp, Louisa Jane Quegan, Anjali Pandey, Juan Wang, Matthew Nieder, Wolin Huang
  • [4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREA SALTS, FORMS AND METHODS RELATED THERETO
    Publication number: 20090042916
    Abstract: The present invention provides novel sulfonylurea salts of a salt of formula (I) and polymorph forms thereof. The compounds in their various forms are effective platelet ADP receptor inhibitors and may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of cardiovascular diseases, particularly those diseases related to thrombosis. The invention also provides a method for preparing such compounds and forms and for preventing or treating thrombosis and thrombosis related conditions in a mammal comprising the step of administering a therapeutically effective amount of a salt of formula (I) or a pharmaceutically acceptable form thereof.
    Type: Application
    Filed: May 2, 2008
    Publication date: February 12, 2009
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Emma Sharp, Louisa Jane Quegan, Anjali Pandey, Juan Wang, Matthew Nieder, Wolin Huang